BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
US Department of Justice
Federal Trade Commission

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,004,286

« Back to Dashboard

Which drugs does patent 6,004,286 protect, and when does it expire?

Patent 6,004,286 protects ZINGO and is included in one NDA.

This patent has eight patent family members in seven countries.

Summary for Patent: 6,004,286

Title: Particle delivery
Abstract:A needleless syringe, in which particles of a therapeutic agent are entrained in a high pressure gas flow, has a nozzle surrounded by a shroud silencer through which gas reflected from the target surface may be vented to atmosphere while retaining any particles reflected in the gas.
Inventor(s): Bellhouse; Brian John (Oxfordshire, GB), Potter; Charles David Ogilvy (Oxon, GB), Greenford; John Christopher (Oxfordshire, GB)
Assignee: PowderJect Research Limited (GB)
Application Number:09/156,421
Patent Claim Types:
see list of patent claims
Delivery; Device;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Powder Pharms
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007RXNoNo► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,004,286

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9605690Mar 19, 1996

International Patent Family for Patent: 6,004,286

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan3602543► Subscribe
Japan2000507131► Subscribe
United Kingdom9605690► Subscribe
European Patent Office0892649► Subscribe
Germany69729634► Subscribe
Canada2247142► Subscribe
Australia1935997► Subscribe
World Intellectual Property Organization (WIPO)9734652► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus